openPR Logo
Press release

Global Radiopharmaceuticals Market Top Company ardinal Health Inc., MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging Inc., Bayer AG

09-30-2017 12:22 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024

Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024

Data Bridge Market Research provides new industry report "Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Ask for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market

Market Segmentation:

The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.

Inquiry Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market
On the basis of type, the global radiopharmaceuticals market is sub-segmented into diagnostic and therapeutic radiopharmaceuticals. In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.

On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into diagnostic procedures and therapeutic procedures. Diagnostic procedures are further sub-segmented into single-photon emission computed tomography (SPECT) radiopharmaceuticals and positron emission tomography (PET) radiopharmaceuticals. Therapeutic procedures are further sub-segmented into beta emitters, alpha emitters and brachy therapy.
On the basis of application, the global radiopharmaceuticals market is sub-segmented into diagnostic application and therapeutic application.

Diagnostic application are further sub-segmented into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Single-photon emission computed tomography (SPECT) includes cardiology, lymphoma, thyroid, neurology and others. Positron emission tomography (PET) includes oncology, cardiology, neurology and others. Therapeutic application is further sub-segmented into thyroid, bone metastasis, lymphoma, endocrine tumours and others.

On the basis of sources, the global radiopharmaceuticals market is sub-segmented into nuclear reactors and cyclotrons.

On the basis of end user, the global radiopharmaceuticals market is sub-segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutesand others. In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.
Competitive Analysis:

The global IoT healthcare market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes IoT healthcare shares for global, Europe, North America, Asia Pacific, and South America.

Read more about Report Visit @ http://databridgemarketresearch.com/reports/global-radiopharmaceuticals-market/

Major Market Competitors:

Some of the major players operating in the global radiopharmaceuticals market are Cardinal Health Inc., MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging Inc., Bayer AG, Bracco Imaging SpA, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, CovidienPlc, Positron Corporation, NTP Radioisotopes Pty. Ltd., Advanced Medical Isotope Corporation, Avid Radiopharmaceuticals, Jubilant Pharma, Actinium Pharmaceuticals Inc., AREVA Meds,Immunomedics Inc., Merck& Co., Inc., Navidea, PETNET Solutions Inc., Eckert & Ziegler, Siemens Healthcare, and Positron Corporation among others.

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Radiopharmaceuticals Market Top Company ardinal Health Inc., MallinckrodtPlc., GE Healthcare, Lantheus Medical Imaging Inc., Bayer AG here

News-ID: 749396 • Views: 1779

More Releases from Data Bridge Market Research

Psychedelic Drugs Market 2020-2027 Sets the Table for Continued Growth | Global …
This Global Psychedelic Drugs Market analysis report puts a light on various segments that are relied upon to witness the quickest business development amid the estimate forecast frame. This report is also wide-ranging which includes market definition, classifications, applications, engagements, market drivers and market restraints that are obtained with the help of SWOT analysis. This report contains a chapter on the Global Psychedelic Drugs Market and all its associated companies
CBD oil Market Is Projected To Witness Vigorous Expansion By 2026 | Dr. Hemp Me. …
This market analysis report unearths the general market conditions, trends, preferences, key players, opportunities, geographical analysis and many other parameters that help drive the business into the right direction. The report can be used to obtain valuable market insights in a commercial way. The information of this CBD oil market report not only restrains the risks of ambiguity but also assists in taking sound decisions while maintaining the reputation of
Global Cannabis Capsule Market 2020-2026 is Growing So Rapidly || Leading Player …
Data Bridge Market Research has recently added a concise research on the Global Cannabis Capsule Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value,
Global Hospitals and Outpatient Care Centers Market 2020-2026 is Growing So Rapi …
Global Hospitals and Outpatient Care Centers Market Type (Government Hospitals, Private Hospitals), Department (Hospitals {Emergency department, Cardiology, Intensive care unit, Paediatric intensive care unit, Neonatal intensive care unit, Cardiovascular intensive care unit, Neurology, Oncology, Obstetrics and Gynaecology}, Outpatient Care Centers {Ambulatory Surgical & Emergency Centers, Kidney Dialysis Centers, General Medical & Surgical Hospitals, Specialty Hospitals, Family Planning Centers, ENT Clinic, Psychiatric & Substance Abuse Hospitals, Outpatient Mental Health & Substance

All 5 Releases


More Releases for Radiopharmaceuticals

Global Radiopharmaceuticals Market Outlook 2020 Report
“Global Radiopharmaceuticals Market Outlook 2020” Report Highlight: * Global Radiopharmaceutical Market Overview * Global Radiopharmaceuticals Market Dynamics * FDA & EMA Guidelines for Radiopharmaceuticals * Global Radiopharmaceuticals Clinical Pipeline Insight by Company, Indication & Phase * Global Radiopharmaceuticals Clinical Pipeline: 133 Radiopharmaceuticals * Majority Radiopharmaceuticals in Preclinical Phase: 44 Radiopharmaceuticals * Marketed Radiopharmaceuticals: 19 Radiopharmaceuticals Download Report Sample Weblink: https://www.kuickresearch.com/report-Global-Radiopharmaceuticals-Market-Outlook-2020.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario
Radiopharmaceuticals Market Estimated to Flourish by 2026
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a